Prognostic potential and tumor growth-inhibiting effect of plasma advanced glycation end products in non-small cell lung carcinoma.

Molecular medicine (Cambridge, Mass.)

Volumn 17, Issue 9-10, 2011, Pages 980-989

  Bartling, Babett ^a   Hofmann, Hans Stefan ^b   Sohst, Antonia ^b   Hatzky, Yvonne ^b   Somoza, Veronika ^b   Silber, Rolf Edgar ^b   Simm, Andreas ^b  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR;

AGED; ANIMAL; ARTICLE; BLOOD; CHEMISTRY; DIET; DISEASE COURSE; EXPERIMENTAL NEOPLASM; FEMALE; FLUORESCENCE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KAPLAN MEIER METHOD; LUNG; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; MOUSE; MULTICELLULAR SPHEROID; NUDE MOUSE; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; TUMOR CELL LINE; TUMOR VOLUME; XENOGRAFT;

AGED; ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DIET; DISEASE PROGRESSION; FEMALE; FLUORESCENCE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASMS, EXPERIMENTAL; PROGNOSIS; RECEPTORS, IMMUNOLOGIC; RETROSPECTIVE STUDIES; SPHEROIDS, CELLULAR; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN;

MLCS; MLOWN;

EID: 81855182736     PISSN: None     EISSN: 15283658     Source Type: Journal    
DOI: 10.2119/molmed.2011.00085     Document Type: Article

References (0)